Brief exposures to NO2 augment the allergic inflammation in asthmatics.
Exposure to high ambient levels of nitrogen dioxide (NO2) enhances the airway reaction in humans to allergen, measured as decreased pulmonary function. We tested whether this NO2 effect is associated with an increased inflammatory response to allergen in the airways. To mimic real-life conditions, in which exposure to high ambient levels of NO2 occurs only during short periods of time but often several times a day, we used a repeated-exposure model. On day 1, 18 subjects with allergic asthma were exposed, in randomized order, to purified air or to 500 microg/m3 NO2 for 15 min, and on day 2 for 2 x 15 min. Allergen was inhaled 3-4h after the NO2 exposures on both days. Symptoms, pulmonary function, and inflammatory response in sputum and blood were measured daily. Eosinophil cationic protein in both sputum and blood increased more from day 1 to day 3 after NO2+allergen than after air+allergen, whereas eosinophil counts did not differ. The change in myeloperoxidase was significantly greater after NO2+allergen than after air+allergen in blood but not in sputum. This finding was not accompanied by raised levels of neutrophils in sputum and blood. Symptoms and pulmonary function were equally affected by NO2+allergen and air+allergen. We conclude that two to three brief exposures to ambient levels of NO2 can prime circulating eosinophils and enhance the eosinophilic activity in sputum in response to inhaled allergen. This might be an important mechanism by which air pollutants amplify the inflammatory reactions in the airways.
Barck
C
C
Division of Respiratory Medicine and Allergology, Department of Medicine, Karolinska Institute at Huddinge University Hospital, S-141 86 Stockholm, Sweden. charlotte.barck@medhs.ki.se
Lundahl
J
J
Halldén
G
G
Bylin
G
G
D000403:Airway Resistance; D000485:Allergens; D001249:Asthma / Q000139:chemically induced / Q000503:physiopathology*; D047150:Eosinophil Cationic Protein / Q000097:blood / Q000378:metabolism; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology*; D009569:Nitric Oxide / Q000009:adverse effects*; D009195:Peroxidase / Q000097:blood; D010993:Plethysmography, Whole Body; D011058:Pollen; D012129:Respiratory Function Tests; D013183:Sputum / Q000737:chemistry; D011795:Surveys and Questionnaires; D013548:Sweden
D000485:Allergens; D009569:Nitric Oxide; D009195:Peroxidase; D047150:Eosinophil Cationic Protein